Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1

Journal: Nature Communications

Published: 2018-12-07

DOI: 10.1038/s41467-018-07517-y

Affiliations: 4

Authors: 8

Go to article
Institutions FC
Department of Imaging Sciences, UR, United States of America (USA) 0.38
Ionis Pharmaceuticals, Inc., United States of America (USA) 0.25
Department of Neurology, MGH, United States of America (USA) 0.19
Harvard Medical School (HMS), United States of America (USA) 0.19

Return